Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets
about
Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric SymptomsMetabolomics of bronchoalveolar lavage differentiate healthy HIV-1-infected subjects from controls.Measuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms: towards addressing the missing heritability in pharmacogenetic phenotypes?Nuclear magnetic resonance based profiling of biofluids reveals metabolic dysregulation in HIV-infected persons and those on anti-retroviral therapyOral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungiQuorum-sensing dysbiotic shifts in the HIV-infected oral metabiomeCorrelation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infectionSerum metabolomics analysis of patients with chikungunya and dengue mono/co-infections reveals distinct metabolite signatures in the three disease conditions.Metabonomic analysis of HIV-infected biofluids.Metabolomics: Applications and Promise in Mycobacterial Disease.Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites?Metabolomic analysis identifies differentially produced oral metabolites, including the oncometabolite 2-hydroxyglutarate, in patients with head and neck squamous cell carcinoma.Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune ActivationA combined chemometric and quantitative NMR analysis of HIV/AIDS serum discloses metabolic alterations associated with disease status.HIV/HAART-associated oxidative stress is detectable by metabonomics.Exploring the effect of dentition, dental decay and familiality on oral health using metabolomics.A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of ART in HIV-infected patients.Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
P2860
Q26800052-6169D11D-D89B-47A9-A0B2-F9836E456F59Q33713799-40F8C64D-FD06-48A1-866A-CF7CF2D57A15Q33720712-192AC515-0B5E-4FE9-8114-51848E37F051Q34734134-E0BC6546-5FEF-42D5-84A4-AE46520D5991Q35120262-F70D4715-AA07-4A5B-837C-5AC7EAF5C281Q35464257-0C3DBE70-6D69-4D2E-A784-3BFB1E6CE7C6Q35899601-92C5DA00-9CEC-4E1D-A6EB-FFD0BB10067DQ37414121-8BBA4F56-6B68-4F1F-925C-34F839E874F9Q38056813-FB801F4F-6536-45E3-AE6B-A975FC5AAB74Q38551411-4AD66781-FCC1-4C8F-A043-CAB25D7DC988Q39238772-7E647952-6857-4373-AF2F-38D8A72220CCQ40283125-A2826B9E-BEB0-48A8-B846-328D37C4FA01Q40625213-60FB8DBF-A2D0-43ED-97CE-59C3F26162C1Q41352945-106AC6B0-1066-4CB5-B403-C78B9FBFBA91Q41935715-D008BA1F-05FA-4629-ADF1-6500C49060DFQ42001647-16243128-58CE-40BC-93B9-1D2015AB98BCQ47216380-DC111981-0DDA-41A8-873F-E855BDEC2C1EQ58549748-376B65E9-58DE-43A9-9E7F-57D28B3995E8
P2860
Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Metabolomics reveals different ...... oward novel diagnostic targets
@ast
Metabolomics reveals different ...... oward novel diagnostic targets
@en
type
label
Metabolomics reveals different ...... oward novel diagnostic targets
@ast
Metabolomics reveals different ...... oward novel diagnostic targets
@en
prefLabel
Metabolomics reveals different ...... oward novel diagnostic targets
@ast
Metabolomics reveals different ...... oward novel diagnostic targets
@en
P2093
P2860
P356
P1476
Metabolomics reveals different ...... oward novel diagnostic targets
@en
P2093
Jennifer Webster-Cyriaque
Mahmoud A Ghannoum
Masoumeh Sikaroodi
Mauricio Retuerto
Patrick M Gillevet
Pranab K Mukherjee
Richard J Jurevic
Robert E Brown
P2860
P356
10.1089/OMI.2011.0035
P577
2011-07-13T00:00:00Z